We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

200 hedge funds and large institutions have $2.1B invested in Bio-Rad Laboratories Class A in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 79 increasing their positions, 72 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 72

0.71% more ownership

Funds ownership: 77.69% → 78.4% (+0.71%)

5% less capital invested

Capital invested by funds: $2.2B → $2.1B (-$101M)

9% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 22

2% less funds holding

Funds holding: 204 → 200 (-4)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
200
Holders Change
-4
Holders Change %
-1.96%
% of All Funds
5.8%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
79
Reduced
72
Closed
22
Calls
$1.01M
Puts
–
Net Calls
+$1.01M
Net Calls Change
-$560K

Top Buyers

Rank Fund Capital Flow
1
EIP
Epoch Investment Partners
New York
+$22.3M
2
AI
Ariel Investments
Illinois
+$9.93M
3
LCS
Levin Capital Strategies
New York
+$9.37M
4
TCM
Tamarack Capital Management
California
+$7.94M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$6.9M

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$18.3M
2
RA
Royce & Associates
New York
-$17.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.8M
4
CIP
Champlain Investment Partners
Vermont
-$14.6M
5
Wells Fargo
Wells Fargo
California
-$10.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
76
D.E. Shaw & Co
New York
$3.17M +$1.45M +12,196 +77%
TAM
77
THB Asset Management
Connecticut
$3.07M -$1.05M -8,820 -25%
Goldman Sachs
78
Goldman Sachs
New York
$2.93M -$851K -7,183 -22%
WS
79
Wedbush Securities
California
$2.82M – – –
STC
80
SEI Trust Company
Pennsylvania
$2.81M -$177K -1,492 -6%
MSA
81
Mason Street Advisors
Wisconsin
$2.73M +$24.8K +209 +0.9%
Two Sigma Advisers
82
Two Sigma Advisers
New York
$2.66M -$746K -6,300 -21%
CS
83
Credit Suisse
Switzerland
$2.59M -$970K -8,185 -26%
LOAMS
84
Lombard Odier Asset Management (Switzerland)
Switzerland
$2.54M +$2.64M +22,259 New
Swiss National Bank
85
Swiss National Bank
Switzerland
$2.46M -$47.4K -400 -2%
Federated Hermes
86
Federated Hermes
Pennsylvania
$2.44M +$116K +983 +5%
AllianceBernstein
87
AllianceBernstein
Tennessee
$2.31M -$4.74K -40 -0.2%
SIM
88
Spark Investment Management
New York
$2.27M – – –
ARC
89
Absolute Return Capital
Massachusetts
$2.21M -$270K -2,276 -10%
ECM
90
EII Capital Management
New York
$2.17M -$1.2M -10,150 -35%
TPSF
91
Texas Permanent School Fund
Texas
$2.11M -$214K -1,807 -9%
HNB
92
Huntington National Bank
Ohio
$2.05M -$10.4K -88 -0.5%
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$1.96M +$46.6K +393 +2%
BG
94
BlackRock Group
United Kingdom
$1.95M +$429K +3,617 +27%
USAA
95
United Services Automobile Association
Texas
$1.86M – – –
BIM
96
Bogle Investment Management
Massachusetts
$1.78M +$1.86M +15,679 New
Comerica Bank
97
Comerica Bank
Texas
$1.76M +$47.4K +400 +3%
PP
98
PDT Partners
New York
$1.75M +$1.83M +15,472 New
Invesco
99
Invesco
Georgia
$1.75M +$693K +5,847 +61%
AAM
100
Advisors Asset Management
Colorado
$1.74M +$363K +3,064 +25%
2 3
4
5 6

BIO Hedge Fund Activity: Q3 2014 in Review

200 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2014, worth a combined $2.1B — down 4.6% from $2.2B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of BIO and 20 opened new positions — a net loss of 2 holders — while 72 trimmed existing stakes and 79 added.

The largest buyer was Epoch Investment Partners, opening a new position worth an estimated $22.3M. The largest seller was Norges Bank, cutting an estimated $18.3M.

  • 200 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2014, down from 204 in Q2 2014.
  • Funds reported $2.1B of Bio-Rad Laboratories Class A stock for Q3 2014, down 4.6% quarter-over-quarter.
  • 20 funds opened new Bio-Rad Laboratories Class A positions in Q3 2014 and 22 closed out, a net change of -2 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2014 was Epoch Investment Partners, an estimated $22.3M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2014 was Norges Bank, an estimated $18.3M sold.

Based on aggregated 13F filings for Q3 2014.